ASCO...
https://money.cnn.com/news/newsfeeds/articles/djf500/200905271356DOWJONESDJONLINE000787_FORTUNE5.htm
Avastin failure and Tarceva failure basically means that other new drugs are badly needed.
Also, personalized approach opens the door for smaller players...
All good news for Thallion.
It's the combo are. Pharma's are facing a double threat, multiple patents expiring and new screening tests arrival where market will fall by half or more based on biomarkers testing...
Well... Pharma need to find a way to replace the loss income.... Answer Leverage buyout of small innovative powerhouse such as Thallion.
Everything points to Thallion...